MWG Management

Latest statistics and disclosures from MWG Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are BEAM, LYEL, PRME, and represent 100.00% of MWG Management's stock portfolio.
  • Reduced shares in these 1 stock: BEAM.
  • MWG Management was a net seller of stock by $-1.9M.
  • MWG Management has $92M in assets under management (AUM), dropping by -32.20%.
  • Central Index Key (CIK): 0001845151

Tip: Access up to 7 years of quarterly data

Positions held by MWG Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for MWG Management

MWG Management holds 3 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Beam Therapeutics (BEAM) 58.0 $53M -3% 2.3M 23.43
 View chart
Lyell Immunopharma (LYEL) 31.9 $29M 20M 1.45
 View chart
Prime Medicine (PRME) 10.1 $9.2M 1.8M 5.14
 View chart

Past Filings by MWG Management

SEC 13F filings are viewable for MWG Management going back to 2020